vs
Enact Holdings, Inc.(ACT)与Orion Group Holdings Inc(ORN)财务数据对比。点击上方公司名可切换其他公司
Enact Holdings, Inc.的季度营收约是Orion Group Holdings Inc的1.4倍($312.7M vs $216.3M),Orion Group Holdings Inc同比增速更快(14.6% vs 3.6%),过去两年Orion Group Holdings Inc的营收复合增速更高(6.1% vs 3.6%)
Enact Holdings, Inc.是美国领先的私人抵押贷款保险服务商,为银行、信用社等各类住宅抵押贷款机构提供风险缓释解决方案,帮助首付较低的购房者获得可负担的住房贷款,助力更多美国普通消费者实现安居需求。
奥里昂集团是源自芬兰的全球化制药企业,1917年成立,总部位于芬兰埃斯波。公司面向全球市场研发、生产并销售人用与兽用药品以及药用活性成分,旗下全部生产基地与大部分研发部门均设立在芬兰。
ACT vs ORN — 直观对比
营收规模更大
ACT
是对方的1.4倍
$216.3M
营收增速更快
ORN
高出11.0%
3.6%
两年增速更快
ORN
近两年复合增速
3.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $312.7M | $216.3M |
| 净利润 | — | $4.7M |
| 毛利率 | — | 12.0% |
| 营业利润率 | 71.3% | — |
| 净利率 | — | 2.2% |
| 营收同比 | 3.6% | 14.6% |
| 净利润同比 | — | 435.7% |
| 每股收益(稀释后) | $1.23 | $0.12 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ACT
ORN
| Q1 26 | — | $216.3M | ||
| Q4 25 | $312.7M | $233.2M | ||
| Q3 25 | $311.5M | $225.1M | ||
| Q2 25 | $304.9M | $205.3M | ||
| Q1 25 | $306.8M | $188.7M | ||
| Q4 24 | $301.8M | $216.9M | ||
| Q3 24 | $309.6M | $226.7M | ||
| Q2 24 | $298.8M | $192.2M |
净利润
ACT
ORN
| Q1 26 | — | $4.7M | ||
| Q4 25 | — | $-240.0K | ||
| Q3 25 | — | $3.3M | ||
| Q2 25 | — | $841.0K | ||
| Q1 25 | — | $-1.4M | ||
| Q4 24 | — | $6.8M | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | — | $-6.6M |
毛利率
ACT
ORN
| Q1 26 | — | 12.0% | ||
| Q4 25 | — | 11.6% | ||
| Q3 25 | — | 13.2% | ||
| Q2 25 | — | 12.6% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | — | 14.0% | ||
| Q3 24 | — | 11.9% | ||
| Q2 24 | — | 9.5% |
营业利润率
ACT
ORN
| Q1 26 | — | — | ||
| Q4 25 | 71.3% | 2.2% | ||
| Q3 25 | 67.4% | 2.4% | ||
| Q2 25 | 70.4% | 1.7% | ||
| Q1 25 | 68.9% | 0.4% | ||
| Q4 24 | 68.9% | 4.4% | ||
| Q3 24 | 74.1% | 3.4% | ||
| Q2 24 | 78.6% | -1.4% |
净利率
ACT
ORN
| Q1 26 | — | 2.2% | ||
| Q4 25 | — | -0.1% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | -0.7% | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | -3.4% |
每股收益(稀释后)
ACT
ORN
| Q1 26 | — | $0.12 | ||
| Q4 25 | $1.23 | $-0.00 | ||
| Q3 25 | $1.10 | $0.08 | ||
| Q2 25 | $1.11 | $0.02 | ||
| Q1 25 | $1.08 | $-0.04 | ||
| Q4 24 | $1.05 | $0.22 | ||
| Q3 24 | $1.15 | $0.12 | ||
| Q2 24 | $1.16 | $-0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $582.5M | $6.3M |
| 总债务越低越好 | $744.5M | — |
| 股东权益账面价值 | $5.4B | $166.7M |
| 总资产 | $6.9B | $478.7M |
| 负债/权益比越低杠杆越低 | 0.14× | — |
8季度趋势,按日历期对齐
现金及短期投资
ACT
ORN
| Q1 26 | — | $6.3M | ||
| Q4 25 | $582.5M | $1.6M | ||
| Q3 25 | $545.6M | $4.9M | ||
| Q2 25 | $616.0M | $1.7M | ||
| Q1 25 | $639.0M | $13.0M | ||
| Q4 24 | $602.8M | $28.3M | ||
| Q3 24 | $674.9M | $28.3M | ||
| Q2 24 | $711.3M | $4.8M |
总债务
ACT
ORN
| Q1 26 | — | — | ||
| Q4 25 | $744.5M | — | ||
| Q3 25 | $744.1M | — | ||
| Q2 25 | $743.8M | $33.4M | ||
| Q1 25 | $743.4M | $23.3M | ||
| Q4 24 | $743.0M | $23.2M | ||
| Q3 24 | $742.7M | $28.0M | ||
| Q2 24 | $742.4M | $60.3M |
股东权益
ACT
ORN
| Q1 26 | — | $166.7M | ||
| Q4 25 | $5.4B | $159.0M | ||
| Q3 25 | $5.3B | $157.9M | ||
| Q2 25 | $5.2B | $153.2M | ||
| Q1 25 | $5.1B | $150.8M | ||
| Q4 24 | $5.0B | $150.7M | ||
| Q3 24 | $5.0B | $142.4M | ||
| Q2 24 | $4.8B | $111.1M |
总资产
ACT
ORN
| Q1 26 | — | $478.7M | ||
| Q4 25 | $6.9B | $414.7M | ||
| Q3 25 | $6.9B | $422.4M | ||
| Q2 25 | $6.8B | $432.7M | ||
| Q1 25 | $6.7B | $416.3M | ||
| Q4 24 | $6.5B | $417.3M | ||
| Q3 24 | $6.6B | $430.3M | ||
| Q2 24 | $6.3B | $414.0M |
负债/权益比
ACT
ORN
| Q1 26 | — | — | ||
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.14× | 0.22× | ||
| Q1 25 | 0.15× | 0.15× | ||
| Q4 24 | 0.15× | 0.15× | ||
| Q3 24 | 0.15× | 0.20× | ||
| Q2 24 | 0.15× | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $724.5M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
ACT
ORN
| Q1 26 | — | — | ||
| Q4 25 | $724.5M | $13.8M | ||
| Q3 25 | $192.0M | $23.3M | ||
| Q2 25 | $119.5M | $-5.6M | ||
| Q1 25 | $226.7M | $-3.4M | ||
| Q4 24 | $686.3M | $13.4M | ||
| Q3 24 | $188.1M | $37.5M | ||
| Q2 24 | $144.7M | $-15.3M |
自由现金流
ACT
ORN
| Q1 26 | — | — | ||
| Q4 25 | — | $454.0K | ||
| Q3 25 | — | $13.9M | ||
| Q2 25 | — | $-12.7M | ||
| Q1 25 | — | $-12.5M | ||
| Q4 24 | — | $9.9M | ||
| Q3 24 | — | $33.3M | ||
| Q2 24 | — | $-20.0M |
自由现金流率
ACT
ORN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 6.2% | ||
| Q2 25 | — | -6.2% | ||
| Q1 25 | — | -6.6% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | — | 14.7% | ||
| Q2 24 | — | -10.4% |
资本支出强度
ACT
ORN
| Q1 26 | — | — | ||
| Q4 25 | — | 5.7% | ||
| Q3 25 | — | 4.2% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 1.8% | ||
| Q2 24 | — | 2.4% |
现金转化率
ACT
ORN
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 7.05× | ||
| Q2 25 | — | -6.61× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.98× | ||
| Q3 24 | — | 8.79× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图